MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 215 filers reported holding MIRATI THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.31 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,994,225 | +3142.3% | 206,479 | +2589.2% | 0.10% | +2525.0% |
| Q2 2023 | $277,406 | -36.0% | 7,678 | -34.1% | 0.00% | -33.3% |
| Q1 2023 | $433,370 | +73.6% | 11,656 | +111.5% | 0.01% | +50.0% |
| Q4 2022 | $249,703 | -37.0% | 5,511 | -51.4% | 0.00% | 0.0% |
| Q3 2022 | $396,396 | +4.0% | 11,346 | +100.0% | 0.00% | -50.0% |
| Q2 2022 | $381,000 | -91.9% | 5,673 | -82.3% | 0.01% | -76.5% |
| Q4 2021 | $4,698,000 | +16.5% | 32,027 | +40.5% | 0.03% | -2.9% |
| Q3 2021 | $4,033,000 | +689.2% | 22,796 | +620.3% | 0.04% | +600.0% |
| Q2 2021 | $511,000 | +81.9% | 3,165 | -65.4% | 0.01% | -76.2% |
| Q1 2018 | $281,000 | – | 9,141 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $136,602,679 | 87.83% |
| EcoR1 Capital, LLC | 5,748,399 | $250,400,260 | 8.45% |
| Boxer Capital, LLC | 3,201,440 | $139,454,726 | 7.42% |
| RTW INVESTMENTS, LP | 6,768,514 | $294,836,470 | 6.22% |
| Paradigm Biocapital Advisors LP | 1,668,116 | $72,663,133 | 4.93% |
| Avoro Capital Advisors LLC | 6,666,666 | $290,399,971 | 4.53% |
| Octagon Capital Advisors LP | 655,051 | $28,534,022 | 4.38% |
| Artal Group S.A. | 2,024,226 | $88,175 | 3.78% |
| Ally Bridge Group (NY) LLC | 70,283 | $3,061,527 | 3.59% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 216,000 | $9,404,640 | 3.17% |